In Brief: Pharmacy pricing suit
Pharmacy pricing suit: Trial date for the pharmacy class action drug pricing discrimination suit set for April 14 by Chicago federal court Judge Charles Kocoras. DuPont Merck has filed for a reconsideration of the ruling reinstating the company as a defendant in the case ("The Pink Sheet" Aug. 25, p. 5)...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth